Dr. Bruno Carneiro De Medeiros, MD is a Internal Medicine Physician - Hematology practicing in Palo Alto, CA
He has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Federal University of Parana | Medical Degree | Not Specified |
| Institution | Focus | Year |
|---|---|---|
| Residency - University of Colorado Denver Affiliated Hospitals | 2002 | |
| Residency - University of Colorado Health Science Center | 2002 | |
| Fellowship - Acute leukemia, Princess Margaret Hospital - University of Toronto | 2006 | |
| Fellowship - University of Colorado Health Science Center CO | 2005 | |
| Fellowship - Acute leukemia, Princess Margaret Hospital - University of Toronto | 2006 | |
| Internship - University of Connecticut Health Center | 2000 | |
| Internship - University of Connecticut Health Center CT | 2000 |
| Certification | Cert. Body | Year |
|---|---|---|
Sub-Specialty: Hematology | Internal Medicine | 2006 |
Sub-Specialty: Medical Oncology | Internal Medicine | 2005 |
| Internal medicine Sub-Specialty: Hematology | Internal Medicine | 2006 |
| Internal medicine Sub-Specialty: Medical Oncology | Internal Medicine | 2005 |
| Position | Organization | Time |
|---|---|---|
| Assistant Professor of Medicine (Hematology) | the Stanford University Medical Center | Present |
| Panel Member | Multiple Myeloma Committee, National Comprehensive Cancer Network | 2007 - 2011 |
| Director | Stanford Hospital Hematology Inpatient service | 2011 - 2013 |
| Director | Stanford Acute Leukemia Clinical Research Program | 2009 - 2013 |
| Panel member | adult oncology committee, National comprehensive cancer network | 2010 - 2013 |
| Acute Leukemia Panel Member | Southwest Oncology Group | 2007 - 2013 |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | Proceedings of the tiol Academy of Sciences of the United States of Am | Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators | 2014 |
| Other Publication | BRITISH JOURL OF HAEMATOLOGY | Unsuccessful diagnostic cytogenetic alysis is a poor prognostic feature in acute myeloid leukaemia | 2014 |
| Other Publication | Haematologica | Sequential azacitidine plus lelidomide combition | 2013 |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURL | Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia | 2012 |
| Other Publication | LEUKEMIA | Safety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for | 2012 |
| Other Publication | AMERICAN JOURL OF HEMATOLOGY | Tailored temozolomide therapy according to MGMT methylation status | 2012 |
| Other Publication | NEW ENGLAND JOURL OF MEDICINE | Cytarabine Dose for Acute Myeloid Leukemia | 2011 |
| Other Publication | Jourl of the tiol Comprehensive Cancer Network | Senior adult oncology, version 2.2014: clinical practice guidelines in oncology . | 2014 |
| Other Publication | HAEMATOLOGICA | Gemtuzumab ozogamicin in combition with vorinostat | 2014 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Hematopoietic Stem Cell Transplantation for Hematologic Maligncies in Older Adults | 2014 |
| Other Publication | Jourl of oncology practice / American Society of Clinical Oncology | Qualitative alysis of practicing oncologists' attitudes | 2013 |
| Other Publication | Leukemia & lymphoma | A single-center experience of the tionwide daunorubicin shortage | 2013 |
| Other Publication | Dinner, S. N., Dunn, T. J., Medeiros, B. C., Coutre, S. E., Berube, C. | Amrubicin, a Novel Investigatiol Anthracycline | |
| Other Publication | Dunn, T. J., Dinner, S. N., Berube, C., Gotlib, J., Coutre, S. E., Med | A Phase I/II Study of Bortezomib | |
| Other Publication | HEMATOLOGY | Hemophagocytic lymphohistiocytosis in pregncy: a case report and review of treatment options | 2012 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Waldenstrom's Macroglobulinemia | 2012 |
| Other Publication | Jourl of the tiol Comprehensive Cancer Network | Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. | 2012 |
| Other Publication | AMERICAN JOURL OF HEMATOLOGY | Absolute lymphocyte count at day 28 independently predicts event-free | 2012 |
| Other Publication | INTERTIOL JOURL OF HEMATOLOGY | Novel agents in acute myeloid leukemia | 2012 |
| Other Publication | JOURL OF GERIATRIC ONCOLOGY | New treatment approaches for older adults with multiple myeloma | 2012 |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURL | Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post | 2012 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Senior Adult Oncology | 2012 |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURL | Phase I trial of a novel human monoclol antibody mAb216 in patients with relapsed or refractory B | 2012 |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURL | Treatment advances have not improved the early death rate in acute promyelocytic leukemia | 2012 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Multiple Myeloma | 2011 |
| Other Publication | BRITISH JOURL OF HAEMATOLOGY | Acute myeloid leukaemia in the elderly: a review | 2011 |
| Other Publication | LAB ON A CHIP | Microfluidic purification and alysis of hematopoietic stem cells from bone marrow | 2011 |
| Other Publication | Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., Go | A Phase I Study of Sequential Azacitidine | 2010 |
| Other Publication | AMERICAN JOURL OF HEMATOLOGY | Second-line mitoxantrone, etoposide | 2010 |
| Other Publication | Expert review of hematology | Plasma cell leukemia: concepts and magement. | 2010 |
| Other Publication | EXPERT REVIEW OF HEMATOLOGY | Plasma cell leukemia: concepts and magement | 2010 |
| Other Publication | AMERICAN JOURL OF HEMATOLOGY | Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with | 2010 |
| Other Publication | Walter, B., Medeiros, B., Nielsen-Stoeck, M., Harrington, E., Powell, | PHASE 2 TRIAL OF VORINOSTAT | 2010 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Multiple Myeloma | 2009 |
| Other Publication | AMERICAN JOURL OF HEMATOLOGY | Thalidomide-induced pneumonitis in a patient with plasma cell leukemia | 2009 |
| Other Publication | Jourl of the tiol Comprehensive Cancer Network | NCCN clinical practice guidelines in oncology: multiple myeloma. | 2009 |
| Other Publication | NEW ENGLAND JOURL OF MEDICINE | Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia | 2009 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Role of CEBPA in Normal Karyotype Acute Myeloid Leukemia | 2009 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Comparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia | 2009 |
| Other Publication | Cases jourl | Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin | 2009 |
| Other Publication | Proceedings of the National Academy of Sciences of the United States o | Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators | 2014 |
| Other Publication | BRITISH JOURNAL OF HAEMATOLOGY | Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature | 2014 |
| Other Publication | Haematologica | Sequential azacitidine plus lenalidomide combination | 2013 |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia | 2012 |
| Other Publication | BLOOD | Blood consult: monosomal karyotype acute myeloid leukemia | 2012 |
| Other Publication | LEUKEMIA | Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide | 2012 |
| Other Publication | CANCER | Impact of residual normal metaphases in core binding factor acute myeloid leukemia | 2012 |
| Other Publication | Blood | Unveiling the complexity of CK+ AML. | 2012 |
| Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Tailored temozolomide therapy according to MGMT methylation status | 2012 |
| Other Publication | NEW ENGLAND JOURNAL OF MEDICINE | Cytarabine Dose for Acute Myeloid Leukemia | 2011 |
| Other Publication | BLOOD | Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia | 2010 |
| Other Publication | LEUKEMIA RESEARCH | Mcl-1 dependence predicts response to vorinostat | 2014 |
| Other Publication | Journal of the National Comprehensive Cancer Network | Senior adult oncology, version 2.2014: clinical practice guidelines in oncology . | 2014 |
| Other Publication | Acta haematologica | Facts about FCE (Fludarabine, Cytarabine, Etoposide) in Acute Myeloid Leukemia. | 2014 |
| Other Publication | HAEMATOLOGICA | Gemtuzumab ozogamicin in combination with vorinostat | 2014 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Older Adults | 2014 |
| Other Publication | Journal of oncology practice / American Society of Clinical Oncology | Qualitative analysis of practicing oncologists' attitudes | 2013 |
| Other Publication | Leukemia & lymphoma | A single-center experience of the nationwide daunorubicin shortage | 2013 |
| Other Publication | LEUKEMIA RESEARCH | CD11b expression and MK+ AML: A sign of impending doom? | 2013 |
| Other Publication | LEUKEMIA & LYMPHOMA | 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia | 2013 |
| Other Publication | LEUKEMIA | CD19(-)CD45(low/-)CD38(high)/CD138(+) plasma cells enrich for human tumorigenic myeloma cells | 2012 |
| Other Publication | Dinner, S. N., Dunn, T. J., Medeiros, B. C., Coutre, S. E., Berube, C. | Amrubicin, a Novel Investigational Anthracycline | |
| Other Publication | Becker, P. S., Medeiros, B. C., Stein, A. S., Appelbaum, F. R., Scott, | Multicenter Phase 2 Trial of G-CSF Priming, Clofarabine | |
| Other Publication | Dunn, T. J., Dinner, S. N., Berube, C., Gotlib, J., Coutre, S. E., Med | A Phase I/II Study of Bortezomib | |
| Other Publication | HEMATOLOGY | Hemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment options | 2012 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Waldenstrom's Macroglobulinemia | 2012 |
| Other Publication | Journal of the National Comprehensive Cancer Network | Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. | 2012 |
| Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Absolute lymphocyte count at day 28 independently predicts event-free | 2012 |
| Other Publication | INTERNATIONAL JOURNAL OF HEMATOLOGY | Novel agents in acute myeloid leukemia | 2012 |
| Other Publication | JOURNAL OF GERIATRIC ONCOLOGY | New treatment approaches for older adults with multiple myeloma | 2012 |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post | 2012 |
| Other Publication | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | Aggressive EBV-associated Lymphoproliferative Disorder | 2012 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Senior Adult Oncology | 2012 |
| Other Publication | LEUKEMIA RESEARCH | It doesn't matter if you're black or white, does it? | 2012 |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B | 2012 |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | Treatment advances have not improved the early death rate in acute promyelocytic leukemia | 2012 |
| Other Publication | Becker, P. S., Medeiros, B. C., Appelbaum, F. R., Scott, B. L., Hendri | Phase 2 Trial of G-CSF Priming, Clofarabine | 2011 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Multiple Myeloma | 2011 |
| Other Publication | EXPERT REVIEW OF HEMATOLOGY | Unfavorable-risk cytogenetics in acute myeloid leukemia | 2011 |
| Other Publication | EXPERT OPINION ON THERAPEUTIC TARGETS | Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer | 2011 |
| Other Publication | BRITISH JOURNAL OF HAEMATOLOGY | Acute myeloid leukaemia in the elderly: a review | 2011 |
| Other Publication | LAB ON A CHIP | Microfluidic purification and analysis of hematopoietic stem cells from bone marrow | 2011 |
| Other Publication | Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., Go | A Phase I Study of Sequential Azacitidine | 2010 |
| Other Publication | Medeiros, B. C., Kohrt, H. E., Rajwanshi, R., Gotlib, J., Coutre, S., | Temozolomide In Acute Myeloid Leukemia | 2010 |
| Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Second-line mitoxantrone, etoposide | 2010 |
| Other Publication | Expert review of hematology | Plasma cell leukemia: concepts and management. | 2010 |
| Other Publication | EXPERT REVIEW OF HEMATOLOGY | Plasma cell leukemia: concepts and management | 2010 |
| Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with | 2010 |
| Other Publication | Walter, B., Medeiros, B., Nielsen-Stoeck, M., Harrington, E., Powell, | PHASE 2 TRIAL OF VORINOSTAT | 2010 |
| Other Publication | LEUKEMIA RESEARCH | Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2) | 2010 |
| Other Publication | Alizadeh, A. A., McClellan, J. S., Gotlib, J. R., Coutre, S., Majeti, | Early Mortality in Acute Promyelocytic Leukemia May Be Higher Than Previously Reported. | 2009 |
| Other Publication | Kohrt, H. E., Patel, S., Ho, M., Owen, T., Majeti, R., Gotlib, J. R., | Is Time of the Essence in Adult Acute Myeloid Leukemia | 2009 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Multiple Myeloma | 2009 |
| Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Thalidomide-induced pneumonitis in a patient with plasma cell leukemia | 2009 |
| Other Publication | Journal of the National Comprehensive Cancer Network | NCCN clinical practice guidelines in oncology: multiple myeloma. | 2009 |
| Other Publication | Medeiros, B. C., Gotlib, J. R., Coutre, S. E., Jones, C., Khan, S. A., | Interim results of protracted low doses of temozolomide in high-risk acute myeloid leukemia | |
| Other Publication | NEW ENGLAND JOURNAL OF MEDICINE | Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia | 2009 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Role of CEBPA in Normal Karyotype Acute Myeloid Leukemia | 2009 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Comparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia | 2009 |
| Other Publication | McGuire, A., Shier, L. R., Gotlib, J., Medeiros, B., Wong, K., Corless | Myelomastocytic Leukemia: A Clinical, Pathologic, and Molecular Genetic Study | 2009 |
| Other Publication | Cases journal | Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin | 2009 |
Accepts New Patients: Yes
Dr. Bruno Carneiro De Medeiros, MD has not yet listed the medications that he commonly prescribes.
